Literature DB >> 8606679

Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.

.   

Abstract

These recommendations update information on the vaccine and antiviral agents available for controlling influenza during the 1996-97 influenza season (superseding MMWR 1995;44(No. RR-3):1-22). The principal changes include information about a) the influenza virus strains included in the trivalent vaccine for 1996-97 and b) extension of the optimal time for influenza vaccination campaigns for persons in high-risk groups.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8606679

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN： 1057-5987


  9 in total

1.  Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company.

Authors:  E Burckel; T Ashraf; J P de Sousa Filho; E Forleo Neto; H Guarino; C Yauti; B Barreto F de; L Champion
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

2.  Pneumococcal immunizations at flu clinics: the impact of community-wide outreach.

Authors:  D Shenson; J Quinley; D DiMartino; P Stumpf; M Caldwell; T Lee
Journal:  J Community Health       Date:  2001-06

3.  Influenza Vaccine Effectiveness Against Pediatric Deaths: 2010-2014.

Authors:  Brendan Flannery; Sue B Reynolds; Lenee Blanton; Tammy A Santibanez; Alissa O'Halloran; Peng-Jun Lu; Jufu Chen; Ivo M Foppa; Paul Gargiullo; Joseph Bresee; James A Singleton; Alicia M Fry
Journal:  Pediatrics       Date:  2017-04-03       Impact factor: 7.124

4.  Delta(12)-prostaglandin J(2) is a potent inhibitor of influenza A virus replication.

Authors:  F Pica; A T Palamara; A Rossi; A De Marco; C Amici; M G Santoro
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

5.  Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae.

Authors:  Herve Tettelin; Vega Masignani; Michael J Cieslewicz; Jonathan A Eisen; Scott Peterson; Michael R Wessels; Ian T Paulsen; Karen E Nelson; Immaculada Margarit; Timothy D Read; Lawrence C Madoff; Alex M Wolf; Maureen J Beanan; Lauren M Brinkac; Sean C Daugherty; Robert T DeBoy; A Scott Durkin; James F Kolonay; Ramana Madupu; Matthew R Lewis; Diana Radune; Nadezhda B Fedorova; David Scanlan; Hoda Khouri; Stephanie Mulligan; Heather A Carty; Robin T Cline; Susan E Van Aken; John Gill; Maria Scarselli; Marirosa Mora; Emilia T Iacobini; Cecilia Brettoni; Giuliano Galli; Massimo Mariani; Filippo Vegni; Domenico Maione; Daniela Rinaudo; Rino Rappuoli; John L Telford; Dennis L Kasper; Guido Grandi; Claire M Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-28       Impact factor: 11.205

6.  Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice.

Authors:  D L Larsen; N Dybdahl-Sissoko; M W McGregor; R Drape; V Neumann; W F Swain; D P Lunn; C W Olsen
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Influenza vaccination and associated factors among Korean cancer survivors : a cross-sectional analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys.

Authors:  Kyung-Hyun Choi; Sang Min Park; Kiheon Lee; Ju Hyun Lee; Joo-Sung Park
Journal:  J Korean Med Sci       Date:  2014-07-30       Impact factor: 2.153

Review 8.  Respiratory viral infections in immunocompetent and immunocompromised persons.

Authors:  R B Couch; J A Englund; E Whimbey
Journal:  Am J Med       Date:  1997-03-17       Impact factor: 4.965

Review 9.  Community respiratory virus infections in immunocompromised patients with cancer.

Authors:  E Whimbey; J A Englund; R B Couch
Journal:  Am J Med       Date:  1997-03-17       Impact factor: 4.965
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.